- Sylmar, California, United States
- On-site
- Full-time
- $114K–$228K per year
- 8+ years
Lead the global HV & ICM franchise evidence generation strategy, ensuring reimbursement, coverage, and economic value are embedded in therapy strategy across all regions.
Compensation
The base pay for this position is $114,000.00 – $228,000.00
Responsibilities
- Own the global HV & ICM franchise evidence generation strategy across US, EMEA, APAC, and CALA
- Lead the value-enablement and evidence strategy, defining health-economic models, value messages, real-world evidence, and clinical/economic endpoints
- Inform product development and clinical strategy from the access perspective
- Align Market Access and Regulatory plans to sequence submission/approval timelines
- Drive clinical aspects related to coding, coverage, and payment pathway design globally
Requirements
- Bachelor’s degree or an equivalent combination of education and work experience
- Nice to have: Advanced degree (MS/MPH/PharmD/MBA) in health economics, health outcomes, health policy
- Nice to have: 12+ years in medical device market access
- Nice to have: Cardiac rhythm management experience
- Nice to have: Expertise in global payment systems